A leaky gut barrier results in increased LPS serum levels in NASH patients as well as murine NASH models and results in a TLR4 activation (Rivera et al., 2007; Farhadi et al., 2008; Csak et al., 2011). Here, TLR4 is linked to metabolic dysfunction-associated steatohepatitis.